Study Questions Link Between Zithromax and Heart-Related Deaths

Researchers from Public Health — Seattle are raising questions about the possible links between the antibiotic Zithromax and heart problems seen in recent research, indicating that they have failed to find any correlation. 

In a Letter to the Editor published in the New England Journal of Medicine on May 15, several researchers indicate that they question whether there is a connection between side effects Zithromax and an increased risk of cardiovascular death. They also note that if such a link exists, the risks are far smaller than those associated with gonorrhea, which Zithromax is frequently used to treat.

The report contradicts the findings of FDA investigators, which issued a Zithromax drug safety communication in March 2013, warning that the antibiotic can cause serious and potentially fatal abnormal heart activity.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The FDA indicated that Zithromax, which is also commonly known as Z-Pak or Zmax, can disrupt the electrical activity of the heart. The agency’s conclusions came after an investigation into the risk of Zithromax heart problems that was started in May 2012, examining data from a number of studies.

Zithromax (azithromycin) is a member of a class of antibacterial drugs known as macrolides, which have been known to cause abnormal heart rhythm problems, including QT interval prolongation. These side effects can lead to a fatal heart condition, known as torsades de pointes.

In May 2012, a study published in the New England Journal of Medicine first warned about the potential heart risks. Researchers found patients were 2.5 times more likely to die due to heart related problems on a five day Zithromax treatment when they compared it to treatment with other antibiotics or no antibiotic therapy.

In this latest study, researchers looked at data on 260,048 patients who were diagnosed with either gonorrhea, chlamydia, or both from 1993 to 2012 from the Oregon Public Health Division and Public Health — Seattle and King County. About 62%, 162,385 patients, received Zithromax. The rest received other antibiotics, primarily tetracycline.

According to the researchers’ findings, which looked for deaths among patients within 10 days after treatment, there were no deaths from cardiovascular causes among patients treated with either Zithromax or any other antibiotic during that entire time period. The only deaths they found within the 10-day period were two suicides, one murder, one drug overdose and one case of rectal cancer.

Researchers note that one major study linking Zithromax to heart problems was conducted among older patients that did not reflect the typical population treated for sexually-transmitted infections. Even that study only found one death out of 144,165 persons, the researchers said.

“Our findings should be reassuring to health care providers who prescribe azithromycin to treat gonorrhea and chlamydia, and they support the conclusion of the (U.S. Centers for Disease Control and Prevention) that research related to possible cardiac toxicity associated with azithromycin should not lead to a change in current treatment guidelines for STDs,” the researchers concluded.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Angiodynamics LifePort Lawsuit Filed Over Risk of the Port Catheters Failing, Causing Severe Injury
Angiodynamics LifePort Lawsuit Filed Over Risk of the Port Catheters Failing, Causing Severe Injury (Posted today)

Complaint comes as a panel of federal judges are scheduled to hear oral arguments later this month, to determine whether all AngioDynamics port catheter lawsuits filed in U.S. District Courts nationwide should be centralized before one judge.

Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades
Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades (Posted 4 days ago)

After decades of medical research and reported Depo-Provera side effects, Pfizer should have known that its birth control shot increases the risks of meningioma brain tumors, yet failed to warn women or the medical community.